Soligenix; Diving into Dusquetide with Chief Scientific Officer Oreola Donini

(2:47)

Soligenix; Diving into Photodynamic Therapy Safety \u0026 Hybryte Treatment with Dr. Ellen Kim.

(5:24)

Soligenix; Diving into HyBryte CTCL Treatment Efficacy and Safety with Dr. Jennifer DeSimone

(7:49)

Soligenix; Diving Deeper Into The Company Itself

(8:25)

Soligenix Investor Overview

(1:37)

Inside Soligenix: Innovations in Rare Disease Therapies

(2:11)

Soligenix; Discussing the Benefits of HyBryte™ CTCL Treatment with Michael W. Young

(13:31)

Soligenix; An Introduction to Christopher J. Schaber

(9:1econd)

Soligenix; Cutaneous Lymphoma Foundation CEO Susan Thornton on HyBryte™

(2:10)

Soligenix ; FDA Awards $2.6 Million Orphan Products Development Grant for Expanded Study of HyBryte™

(3:4)

Soligenix, Inc. (NASDAQ: SNGX)

(32:45)

Silfra Fissure - Dive Between Two Continental Plates

(3:48)

RedChip Investor Group Call with Soligenix (NASDAQ: SNGX)

(48:59)

Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

(12:1econd)

Soligenix; An Introduction to Chief Scientific Officer Dr. Oreola Donini

(6:22)

Soligenix CEO Dr.Christopher Schaber on Ricin poisoning \u0026 Soligenix's RiVax™

(2:32)

Soligenix - Filling Urgent Healthcare Needs by Targeting Unaddressed Rare Diseases

(36:54)

Soligenix

(2:23)